nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Challenges in the current antiangiogenic treatment paradigm for patients with non-small cell lung cancer
|
Wozniak, Antoinette |
|
2012 |
82 |
2 |
p. 200-212 13 p. |
artikel |
2 |
Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates
|
Aft, Rebecca |
|
2012 |
82 |
2 |
p. 233-248 16 p. |
artikel |
3 |
Disseminated and circulating tumor cells in gastrointestinal oncology
|
Bidard, F.C. |
|
2012 |
82 |
2 |
p. 103-115 13 p. |
artikel |
4 |
Editorial Board
|
|
|
2012 |
82 |
2 |
p. CO2- 1 p. |
artikel |
5 |
Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence
|
Singhal, Ashish |
|
2012 |
82 |
2 |
p. 116-140 25 p. |
artikel |
6 |
Neoadjuvant therapy in early-stage breast cancer
|
Moreno-Aspitia, Alvaro |
|
2012 |
82 |
2 |
p. 187-199 13 p. |
artikel |
7 |
Optimizing targeted cancer therapy: Towards clinical application of systems biology approaches
|
Sikkema, Arend H. |
|
2012 |
82 |
2 |
p. 171-186 16 p. |
artikel |
8 |
Place of modern imaging modalities for solitary plasmacytoma: Toward improved primary staging and treatment monitoring
|
Chargari, Cyrus |
|
2012 |
82 |
2 |
p. 150-158 9 p. |
artikel |
9 |
Primary plasma cell leukemia in the era of new drugs: Has something changed?
|
Musto, Pellegrino |
|
2012 |
82 |
2 |
p. 141-149 9 p. |
artikel |
10 |
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
|
Rosti, Gianantonio |
|
2012 |
82 |
2 |
p. 159-170 12 p. |
artikel |
11 |
Spinal analgesia for advanced cancer patients: An update
|
Mercadante, Sebastiano |
|
2012 |
82 |
2 |
p. 227-232 6 p. |
artikel |
12 |
Tailored imaging of islet cell tumors of the pancreas amidst increasing options
|
Fiebrich, Helle-Brit |
|
2012 |
82 |
2 |
p. 213-226 14 p. |
artikel |